[go: up one dir, main page]

AU5034099A - Method for identifying a presenilinase inhibitor - Google Patents

Method for identifying a presenilinase inhibitor

Info

Publication number
AU5034099A
AU5034099A AU50340/99A AU5034099A AU5034099A AU 5034099 A AU5034099 A AU 5034099A AU 50340/99 A AU50340/99 A AU 50340/99A AU 5034099 A AU5034099 A AU 5034099A AU 5034099 A AU5034099 A AU 5034099A
Authority
AU
Australia
Prior art keywords
presenilinase
inhibitor
identifying
presenilinase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50340/99A
Inventor
Katja Fechteler
Christian Haass
Harald Steiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of AU5034099A publication Critical patent/AU5034099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50340/99A 1998-07-09 1999-07-08 Method for identifying a presenilinase inhibitor Abandoned AU5034099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98112688 1998-07-09
EP98112688 1998-07-09
PCT/EP1999/004805 WO2000003248A1 (en) 1998-07-09 1999-07-08 Method for identifying a presenilinase inhibitor

Publications (1)

Publication Number Publication Date
AU5034099A true AU5034099A (en) 2000-02-01

Family

ID=8232244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50340/99A Abandoned AU5034099A (en) 1998-07-09 1999-07-08 Method for identifying a presenilinase inhibitor

Country Status (7)

Country Link
EP (1) EP1095279A1 (en)
JP (1) JP2002520031A (en)
AR (1) AR020107A1 (en)
AU (1) AU5034099A (en)
CA (1) CA2332344A1 (en)
UY (1) UY25604A1 (en)
WO (1) WO2000003248A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10000161A1 (en) * 2000-01-06 2001-07-19 Boehringer Ingelheim Pharma Method of identifying a protease inhibitor
AU2001249717B2 (en) * 2000-04-03 2006-03-30 Bristol-Myers Squibb Company Fluorescence assay for gamma-secretase activity and inhibitors
EP3796980A4 (en) * 2018-05-22 2022-03-23 The Brigham & Women's Hospital, Inc. GENE THERAPY FOR ALZHEIMER'S DISEASE
EP3976637A4 (en) 2019-05-24 2023-07-12 The Brigham and Women's Hospital, Inc. GENE THERAPY FOR ALZHEIMER'S DISEASE
MX2022006499A (en) 2019-11-29 2022-08-15 Paros Bio Inc Gene therapy for neurodegenerative disorders.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997027296A1 (en) * 1996-01-26 1997-07-31 Hsc Research And Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
GB9608657D0 (en) * 1996-04-26 1996-07-03 Smithkline Beecham Plc Novel treatment
CA2288227A1 (en) * 1997-04-24 1998-10-29 The General Hospital Corporation A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2

Also Published As

Publication number Publication date
WO2000003248A1 (en) 2000-01-20
EP1095279A1 (en) 2001-05-02
AR020107A1 (en) 2002-04-10
CA2332344A1 (en) 2000-01-20
JP2002520031A (en) 2002-07-09
UY25604A1 (en) 2000-02-23

Similar Documents

Publication Publication Date Title
AU2001290616A1 (en) A method for identifying polymorphisms
AU3186199A (en) A method for optimizing risk management
AU2001294745A1 (en) System and method for identifying a product
AU2829399A (en) Method for introducing solder into a system
AU2048700A (en) A method for increasing electronic business
AU2340997A (en) A method for inhibiting clot formation
EP0897800B8 (en) A recording method
AU6627698A (en) Method for sterilising a sample
AU2452899A (en) Method for etching
AU1337099A (en) Method for identifying micro-organisms
AU2620899A (en) Method for introducing solder into a system
AU6645398A (en) Method for protecting bytecode
AU6925298A (en) Method for machining a crankshaft
AU5034099A (en) Method for identifying a presenilinase inhibitor
AU3981799A (en) Method for identifying genes
AU1034700A (en) A method for identifying bad frames
AU2001283792A1 (en) Method for automatically identifying a directed structure
AU9013498A (en) Method for a bending procedure
AU4784799A (en) Method for forming a nickel-titan plating
AU2649699A (en) A method for manufacturing a cable
AU1723599A (en) A method for identifying new anti-picornaviral compounds
AU6350099A (en) Contaminant removal method
AU5868798A (en) Method for reducing a carbonyl-containing compound
AU3789100A (en) Method for utilizing waste
AU2002223099A1 (en) A method for identifying enzyme inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase